NCT07618312

Brief Summary

Hybrid Type II Implementation Trial

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
36mo left

Started Mar 2027

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2026

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
9 months until next milestone

Study Start

First participant enrolled

March 1, 2027

Expected
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2030

Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

2.8 years

First QC Date

February 10, 2026

Last Update Submit

May 26, 2026

Conditions

EngagementDepression Disorder

Outcome Measures

Primary Outcomes (1)

  • Beck Depression Inventory (21 items)

    Baseline, After 12 weeks, After 32 weeks

Secondary Outcomes (1)

  • Behavioral Activation for Depression Scale Short Form, Session Attendance, Activation Homework

    weekly for 12 weeks

Study Arms (2)

Treatment

EXPERIMENTAL

Administration of Behavioral Activation via Telehealth

Behavioral: Behavioral Activation

Waitlist

NO INTERVENTION

waiting for BA intervention or post intervention

Interventions

Behavioral ActivationBEHAVIORAL

Adapted version of BA intervention delivered via telehealth

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Spanish-speaking adult who prefers to receive services in Spanish
  • Resident of a rural or frontier community in Montana or New Mexico
  • Positive screen for depressive symptoms at or above study eligibility threshold on Spanish-language screening measure
  • Able and willing to participate in telehealth sessions
  • Able to provide informed consent

You may not qualify if:

  • Active suicidal intent requiring immediate emergency intervention
  • Current psychosis or mania
  • Severe cognitive impairment that would prevent participation
  • Currently receiving intensive psychiatric treatment that would conflict with the intervention
  • Unable to participate in telehealth sessions
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Sally Moyce, PhD RN

CONTACT

14069942787sally.moyce@montana.edu

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2026

First Posted

June 1, 2026

Study Start (Estimated)

March 1, 2027

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

February 1, 2030

Last Updated

June 1, 2026

Record last verified: 2026-05